Genetic and phenotypic characterization of a‑next‑generation live-attenuated yellow fever vaccine

Yellow fever remains a global health concern, with limited vaccine supply and risks of severe adverse effects prompting the need for safer, scalable alternatives. Regulatory standards demand thorough genetic and phenotypic characterization to ensure consistency.

See how advanced sequencing and analytical tools can support vaccine development by confirming genetic stability and phenotypic integrity across GMP-relevant stages.